1. Home
  2. JOE vs SUPN Comparison

JOE vs SUPN Comparison

Compare JOE & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JOE
  • SUPN
  • Stock Information
  • Founded
  • JOE 1936
  • SUPN 2005
  • Country
  • JOE United States
  • SUPN United States
  • Employees
  • JOE N/A
  • SUPN N/A
  • Industry
  • JOE Homebuilding
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • JOE Real Estate
  • SUPN Health Care
  • Exchange
  • JOE Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • JOE 2.9B
  • SUPN 2.6B
  • IPO Year
  • JOE N/A
  • SUPN 2012
  • Fundamental
  • Price
  • JOE $52.23
  • SUPN $44.15
  • Analyst Decision
  • JOE
  • SUPN Buy
  • Analyst Count
  • JOE 0
  • SUPN 2
  • Target Price
  • JOE N/A
  • SUPN $43.00
  • AVG Volume (30 Days)
  • JOE 228.2K
  • SUPN 645.4K
  • Earning Date
  • JOE 10-22-2025
  • SUPN 11-03-2025
  • Dividend Yield
  • JOE 1.08%
  • SUPN N/A
  • EPS Growth
  • JOE 16.57
  • SUPN 1411.53
  • EPS
  • JOE 1.42
  • SUPN 1.14
  • Revenue
  • JOE $426,624,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • JOE N/A
  • SUPN $4.84
  • Revenue Next Year
  • JOE N/A
  • SUPN $17.69
  • P/E Ratio
  • JOE $36.56
  • SUPN $39.74
  • Revenue Growth
  • JOE 10.09
  • SUPN 5.55
  • 52 Week Low
  • JOE $40.19
  • SUPN $29.16
  • 52 Week High
  • JOE $62.49
  • SUPN $46.79
  • Technical
  • Relative Strength Index (RSI)
  • JOE 56.55
  • SUPN 54.84
  • Support Level
  • JOE $50.18
  • SUPN $45.26
  • Resistance Level
  • JOE $52.62
  • SUPN $46.72
  • Average True Range (ATR)
  • JOE 1.22
  • SUPN 1.09
  • MACD
  • JOE 0.18
  • SUPN -0.38
  • Stochastic Oscillator
  • JOE 82.55
  • SUPN 12.86

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: